A Registry of De Winter Symdrome of Single Center

April 11, 2021 updated by: Liao Wang, Hainan People's Hospital

A Registry of De Winter Symdrome of Hainan General Hospital

This registry started January 1,2018 to collect patients who diagnosed as De Winter Symdrome for the first time in Hainan General Hospital.All enrolled patients will receive 30 days followed-up.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Hainan
      • Haikou, Hainan, China, 570311
        • Recruiting
        • Hainan General Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All acute coronary syndrome patients with a de Winter syndrome ECG pattern

Description

Inclusion Criteria:

  • Index ECG ST segment showed a 1- to 3-mm upsloping ST-segment depression at the J point in leads V1 to V6 that continued into tall, positive symmetrical T waves
  • Received coronary angiography during hospitalization

Exclusion Criteria:

-No coronary angiography results was available during hospitalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
DeWinterCohort
Patients with de Winter syndrome pattern ECG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with MACEs within 30 days
Time Frame: 30 days
Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with MACEs In-hospital
Time Frame: throughout current hospitalization
Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in-hospital
throughout current hospitalization
Number of Participants with MACEs within 7 days after admitted
Time Frame: 7 days after admitted
Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in 7 days
7 days after admitted

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hainan People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

October 8, 2018

First Submitted That Met QC Criteria

October 14, 2018

First Posted (Actual)

October 16, 2018

Study Record Updates

Last Update Posted (Actual)

April 13, 2021

Last Update Submitted That Met QC Criteria

April 11, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Reg001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ACS - Acute Coronary Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe